Non-Pharmacological Interventions to Prevent Oropharyngeal Candidiasis in Patients Using Inhaled Corticosteroids: A Narrative Review
Open Access
- 17 July 2025
- journal article
- review article
- Published by MDPI AG in Healthcare
- Vol. 13 (14) , 1718
Abstract
Inhaled corticosteroids (ICSs) are widely used to manage chronic respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and human immunodeficiency virus (HIV). However, prolonged use of ICS is associated with the development of oropharyngeal candidiasis, a fungal infection primarily caused by Candida albicans, due to local immunosuppression in the oral cavity. The incidence of oropharyngeal candidiasis varies depending on geographic region, patient age, and comorbidities, with immunocompromised individuals, those with diabetes, and the elderly being particularly vulnerable. Key risk factors include high ICS doses, poor oral hygiene, and improper use of inhalers. Prevention is the cornerstone of managing oropharyngeal candidiasis associated with the chronic use of inhaled corticosteroids. Patient education on proper inhaler technique and oral hygiene is essential to reduce the risk of fungal overgrowth in the oral cavity. Additional preventive strategies include the use of spacers, mouth rinsing after inhalation, and proper denture care. In cases where these measures fail to prevent the infection, prompt detection and early intervention are crucial to prevent progression or recurrence. This narrative review aims to analyze the most effective prophylactic measures to prevent oropharyngeal candidiasis associated with the chronic use of inhaled corticosteroids, emphasizing patient education, oral hygiene, and proper use of inhalation devices.Keywords
Funding Information
- General Directorate of Research of Universidad Santiago de Cali (DGI-01-2025)
This publication has 80 references indexed in Scilit:
- Implementation of mouth rinsing after use of inhaled corticosteroids in AustraliaInternational Journal of Clinical Pharmacy, 2020
- Inhaled Corticosteroids in Chronic Obstructive Pulmonary DiseaseClinics in Chest Medicine, 2020
- Candidiasis: Red and White Manifestations in the Oral CavityHead and Neck Pathology, 2019
- Streptococcus mutans, Streptococcus sobrinus and Candida albicans in oral samples from caries-free and caries-active childrenEuropean Archives of Paediatric Dentistry, 2016
- Oral Candida isolates and fluconazole susceptibility patterns in older Mexican womenArchives of Gerontology and Geriatrics, 2016
- Local, systemic, demographic, and health-related factors influencing pathogenic yeast spectrum and antifungal drug administration frequency in oral candidiasis: a retrospective studyClinical Oral Investigations, 2015
- Pseudomembranous Type of Oral Candidiasis is Associated with Decreased Salivary Flow Rate and Secretory Immunoglobulin A LevelsMycopathologia, 2015
- Inhaled Corticosteroids and the Occurrence of Oral Candidiasis: A Prescription Sequence Symmetry AnalysisDrug Safety, 2013
- Epidemiology of Candidaemia in Europe: Results of 28-Month European Confederation of Medical Mycology (ECMM) Hospital-Based Surveillance StudyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- Systemic Adverse Effects of Inhaled Corticosteroid TherapyArchives of internal medicine (1960), 1999